Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Gains from Sales and Divestitures: 2020

  • Cogent Biosciences' Gains from Sales and Divestitures was N/A to $80,400 in Q4 2020 from the same period last year, while for Dec 2020 it was $80,400, marking a year-over-year change of. This contributed to the annual value of $80,400 for FY2020, which is N/A change from last year.
  • Cogent Biosciences' Gains from Sales and Divestitures amounted to $80,400 in Q4 2020.
  • Cogent Biosciences' 5-year Gains from Sales and Divestitures high stood at $80,400 for Q4 2020, and its period low was $80,400 during Q4 2020.
  • Moreover, its 1-year median value for Gains from Sales and Divestitures was $80,400 (2020), whereas its average is $80,400.